KYV-101
KYSA-5
Phase 2 mab active
Quick answer
KYV-101 for Systemic Sclerosis is a Phase 2 program (mab) at Kyverna Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Kyverna Therapeutics
- Indication
- Systemic Sclerosis
- Phase
- Phase 2
- Modality
- mab
- Status
- active